Cash Flow | Glaxosmithkline Pharmaceuticals Ltd. | R Wadiwala Securities Pvt Ltd

GLAXOSMITHKLINE PHARMACEUTICALS LTD.

NSE : GLAXOBSE : 500660ISIN CODE : INE159A01016Industry : Pharmaceuticals & DrugsHouse : Glaxosmithkline - MNC
BSE3144.45-25.7 (-0.81 %)
PREV CLOSE (Rs.) 3170.15
OPEN PRICE (Rs.) 3190.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 2185
TODAY'S LOW / HIGH (Rs.)3116.05 3194.20
52 WK LOW / HIGH (Rs.)1924.3 3515.95
NSE3138.40-35.2 (-1.11 %)
PREV CLOSE( Rs. ) 3173.60
OPEN PRICE (Rs.) 3184.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 3138.40 (1100)
VOLUME 52526
TODAY'S LOW / HIGH(Rs.) 3112.50 3195.60
52 WK LOW / HIGH (Rs.)1921 3515.7

Cash Flow

Select year
ParticularsMar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax12551.879598.038414.9424756.487230.95
Adjustment-684.09-451.30-400.03-16364.84-256.41
Changes In working Capital1848.28610.21-457.461198.72457.46
Cash Flow after changes in Working Capital13716.059756.957557.469590.367432.00
Cash Flow from Operating Activities12898.975820.164842.258107.485779.11
Cash Flow from Investing Activities-458.0187.128078.51-4055.084180.26
Cash Flow from Financing Activities-7694.20-5614.97-15433.23-5242.42-6955.60
Net Cash Inflow / Outflow4746.77292.30-2512.46-1190.023003.78
Opening Cash & Cash Equivalents641.71349.412861.874051.891048.12
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANANANA
Effect of Foreign Exchange FluctuationsNANANANANA
Closing Cash & Cash Equivalent5388.48641.71349.412861.874051.89